Trade & Exports

The Xi-Trump state-visit track and China's export-leverage track still run in parallel, and the newest evidence is neither a customs figure nor a summit deliverable: a joint notice of the National Financial Regulatory Administration and MOFCOM (Jin Fa No. 17), circulated in late September, expands domestic trade credit insurance (内贸险) to serve the "expand domestic demand" strategy and "domestic-foreign trade integration" (内外贸一体化), with pilot regions from Beijing, Jiangsu, Fujian and Guangdong to Ningbo, Shenzhen, Hunan and Sichuan ¹. The standing judgment holds — Beijing is adding instruments and platforms, not conceding market access. Nothing in this batch shows a tariff rollback or a purchase commitment attached to the state visit.

The insurance notice is the domestic mirror of the export-control squeeze. As tariffs and anti-dumping exposure abroad rise, the policy answer is to make it easier for exporters to sell at home: sharing vetted enterprise lists between commerce authorities and insurers, chain-based underwriting anchored in lead firms, and new coverage tailored to services, digital and green trade ¹. That is the same logic as Liaoning's consumption-promotion month — ticket-stub vouchers across 25,000 merchants in nine scenarios ² — but upgraded from a provincial promotion to a national financial-regulatory instrument. "Integration of internal and external trade" is being made operational precisely because external demand is contested.

The leverage instrument actually on the table is still export control. MOFCOM Announcement No. 40 of 22 September, issued with Public Security, Emergency Management, Customs and NMPA, put two more precursor chemicals under licence for shipment to the United States, Mexico and Canada, while Myanmar, Laos and Afghanistan stay on the separate part-2 list ³ — the named destinations are exactly the fentanyl-enforcement corridor Washington negotiates over. On the same track, Li Qiang personally opened the 5th Global Digital Trade Expo in Hangzhou on 23 September, pitching open-source AI as a "digital ladder" and calling for freer, more inclusive, better-governed trade to some 1,200 delegates from nearly 50 countries, with Malaysia's Anwar and Kyrgyzstan's Kasymaliev in person ^4,5. Diversification scaffolding keeps thickening in parallel: the CAFTA 3.0-themed China-ASEAN Expo drew 3,400-plus firms from over 70 countries ⁶, and CIFTIS closed with MOFCOM pledging high-standard services opening ⁷.

The limit is that domestic demand is the declared offset, not a substitute. NBS August data show industrial value added up 5.2%, equipment manufacturing up 12.1% and high-tech manufacturing up 16.7%, with lithium-ion battery output up 57.2%, industrial robots up 34.6% and 3D printing equipment up 29.9% ⁸. Output keeps outrunning domestic absorption, so foreign buyers must take the difference — which is why anti-dumping exposure against Chinese goods persists regardless of summit choreography. Credit insurance and consumption vouchers soften that gap at the margin; they do not close it at these growth rates.

Washington's side of the ledger is also being updated. USTR's Federal Register request for comments on "Significant Foreign Trade Barriers" for the 2027 National Trade Estimate Report ⁹ shows the US is compiling next year's casebook of complaints against trading partners — the bilateral friction track runs on its own calendar. Adjacent US regulatory activity, such as the order renewing Aeroflot's temporary denial of export privileges ¹⁰, confirms the environment stays restrictive even where China policy is not the direct target.

Net: Beijing is pairing export-side leverage (precursor licensing, export controls) with domestic-side absorption (trade credit insurance, consumption stimulus) and multilateral venue-building (digital trade, CAFTA 3.0), while Washington assembles its 2027 barrier file. Watch four things: whether the Xi visit yields a concrete tariff rollback or purchase deal; whether the precursor-licence regime is tightened or eased as a bargaining chip; whether CAFTA 3.0 moves from expo theme to a signed protocol; and whether the domestic trade-insurance pilots produce hard uptake data or remain a paper instrument.